Delivery Order SPE2DB24D9223-SPE2DB25FKELN
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,728.70 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order covers the supply of Avastin 100 mg/4 mL vials and was issued without a set-aside designation. The contract was awarded under DMS Pharmaceutical Group's existing...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,599.00 contract was awarded on January 26, 2022 by the Defense Logistics Agency (DLA) for the supply of Avastin 100 mg/4 ml vials. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,827.48 contract is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,870.08 contract is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,250.56 contract was awarded by the Defense Logistics Agency (DLA) on July 11, 2023 and has an ultimate completion date of August 1, 2023. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,480.68 contract is for the delivery of Avastin 400 mg/16 ml vials, with a period of performance through February 22, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,387.80 contract is for the delivery of Avastin 100 mg/4 ml vials and has an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- The Defense Logistics Agency Troop Support Medical awarded a $12,867.51 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the provision of 400 mg/16 ml vials of Avastin. The place of performance is Park Ridge, Illinois and the period of performance is from August 29, 2023 through September 20, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing contract vehicle. The award was made without...
- The Defense Logistics Agency awarded a $2,250.56 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 100 mg/4 ml vials of Avastin. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceuticals and medical supplies to various Department of Defense components. DMS Pharmaceutical Group will fulfill the order from its facility in Park Ridge, Illinois by August 4, 2023 to support DLA's medical product procurement programs. No...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,612.00, is for the supply of Avastin 100 mg/4 ml vial (4 ml) to support the medical supply needs of military health facilities. The delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract with the DLA, which...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKELNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,418.88 to DMS Pharmaceutical Group Inc. for Avastin 400 mg/16 ml vials on September 8, 2025, with completion expected by September 29, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Avastin is a branded bevacizumab product used in oncology treatment, reflecting the Defense Logistics Agency's ongoing requirement to supply specialized pharmaceuticals to military health facilities. This delivery order derives from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valued through November 2026 that enables the issuance of firm fixed-price orders for comprehensive pharmaceutical products supporting Department of Defense healthcare needs worldwide. The contractor has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's track record demonstrates reliable delivery of specialized medications including oncology treatments, vaccines, and other critical pharmaceutical products to military health facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 9/8/25 |